Sign In
Buy QGEN
$41.40
-0.0500 (-0.121%)
At Close: Jul 31, 2026
Qiagen Stock gains As Non COVID Sales Boosts Q2 Topline, Bottom-line
08:26am, Friday, 30'th Jul 2021
Qiagen N.V. (NYSE: QGEN) reported after the close of the market Thursday that its second-quarter revenues jumped 28% Y/Y as growth in its core product portfolio tempered, flagging non-COVID-19-rela
Qiagen (QGEN) Beats Q2 Earnings and Revenue Estimates
09:17pm, Thursday, 29'th Jul 2021
Qiagen (QGEN) delivered earnings and revenue surprises of 1.52% and 0.88%, respectively, for the quarter ended June 2021. Do the numbers hold clues to what lies ahead for the stock?
Qiagen Stock Drops After Trimming FY21 Earnings Forecast On Weaker COVID-19 Testing Trends
12:53pm, Monday, 12'th Jul 2021
Qiagen NV (NYSE: QGEN) has reported higher-than-expected second-quarter interim earnings but lowered its outlook on weaker demand for COVID-19 tests, sending its shares lower. The company expects Q
Qiagen cuts outlook on weaker COVID-19 testing trends, shares fall
12:17pm, Monday, 12'th Jul 2021
U.S.-German genetic testing company Qiagen NV reported higher-than-expected second-quarter earnings on Monday but lowered its outlook on weaker demand for COVID-19 tests, sending its shares lower in N
QIAGEN N.V. Conference Call on July 13 to Discuss Preliminary Q2 2021 Results
11:55am, Monday, 12'th Jul 2021
VENLO, the Netherlands--(BUSINESS WIRE)--QIAGEN N.V. conference call on July 13 to discuss preliminary Q2 2021 results
Qiagen stock reverses lower after upbeat Q2 outlook, but downbeat Q3 view
11:40am, Monday, 12'th Jul 2021
Shares of Qiagen N.V. slumped 4.5% in morning trading Monday, reversing an earlier intraday gain of as much 1.7%, after the Netherlands-based biotechnology company provided an upbeat second-quarter re
VENLO, the Netherlands--(BUSINESS WIRE)---- $QGEN #earnings--QIAGEN announces preliminary Q2 2021 results exceeding outlook, updates full-year 2021 outlook
QIAGEN's (QGEN) NeuMoDx HAdV Quant Assay Wins CE-IVD Mark
12:57am, Sunday, 11'th Jul 2021
QIAGEN's (QGEN) NeuMoDx solutions at present offer CE-IVD tests for various viral and bacterial pathogens.
QIAGEN's (QGEN) NeuMoDx HAdV Quant Assay Wins CE-IVD Mark
08:16am, Friday, 09'th Jul 2021
QIAGEN's (QGEN) NeuMoDx solutions at present offer CE-IVD tests for various viral and bacterial pathogens.
QIAGEN's NeuMoDx™ HAdV Quant Assay Secures CE-IVD Certification for Automated Testing to Detect Human Adenovirus Infections
04:22pm, Thursday, 08'th Jul 2021
GERMANTOWN, Md. & HILDEN, Germany--(BUSINESS WIRE)---- $QGEN #adenovirus--QIAGEN's NeuMoDx™ HAdV Quant Assay secures CE-IVD certification for automated testing to detect human adenovirus infections
QIAGEN (QGEN) Faces COVID-Support Sales Drop, Huge Debt
09:46am, Wednesday, 07'th Jul 2021
With gradually falling COVID-19 cases, since the beginning of 2021, QIAGEN's (QGEN) COVID-19 testing related product lines are seeing significant decline in sales.
QIAGEN (QGEN), Sysmex Ink Cancer Companion Diagnostics Deal
09:01am, Monday, 05'th Jul 2021
QIAGEN (QGEN) and Sysmex collaborate to develop and commercialize cancer companion diagnostics.
HILDEN, Germany & GERMANTOWN, Md. & KOBE, Japan--(BUSINESS WIRE)---- $QGEN #cdx--QIAGEN forms strategic alliance with Sysmex Corporation for global cancer companion diagnostics development and commerc
QIAGEN (QGEN) & Verogen Team Up to Employ NGS-Based Forensics
11:03am, Wednesday, 30'th Jun 2021
QIAGEN's (QGEN) new collaboration will offer customers advanced tools and comprehensive support for HID workflows in laboratories.
Verogen Partners with QIAGEN to Deliver Innovative Solutions for Human Identification Laboratories
04:07pm, Tuesday, 29'th Jun 2021
SAN DIEGO & HILDEN, Germany & GERMAN TOWN, Md.--(BUSINESS WIRE)-- #DNAprofiling--QIAGEN N.V. (NYSE: QGEN) (Frankfurt Prime Standard: QIA) and Verogen Inc. today announced a partnership to provide labo
